procyanidin has been researched along with indican in 1 studies
| Studies (procyanidin) | Trials (procyanidin) | Recent Studies (post-2010) (procyanidin) | Studies (indican) | Trials (indican) | Recent Studies (post-2010) (indican) |
|---|---|---|---|---|---|
| 4,116 | 136 | 2,747 | 1,084 | 54 | 667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Lu, F; Lu, Z; Zeng, Y; Zheng, Y; Zou, C | 1 |
1 other study(ies) available for procyanidin and indican
| Article | Year |
|---|---|
Grape seed proanthocyanidin extract protects human umbilical vein endothelial cells from indoxyl sulfate-induced injury via ameliorating mitochondrial dysfunction.
Topics: Antigens, CD; Apoptosis; Cadherins; Cardiovascular Diseases; Drug Evaluation, Preclinical; Endothelial Cells; Grape Seed Extract; Human Umbilical Vein Endothelial Cells; Humans; Indican; Mitochondria; Nitric Oxide Synthase Type III; Phytotherapy; Proanthocyanidins; Reactive Oxygen Species; Renal Insufficiency, Chronic; Vitis | 2016 |